Role of K+ channels in M2 muscarinic receptor-mediated inhibition of noradrenaline release from the rat stomach

Journal of Pharmacological Sciences

Volumn 96, Issue 3, 2004, Pages 286-292

  Nakamura, Kumiko ^a   Okada, Shoshiro ^a   Yamaguchi, Naoko ^a   Shimizu, Takahiro ^a   Yokotani, Keiko ^a   Yokotani, Kunihiko ^a  

^a KOCHI UNIVERSITY   (Japan)

Author keywords

K+ channel; Muscarinic inhibition; Noradrenaline release; Rat stomach; Sympathetic nerve

Indexed keywords

4 AMINOPYRIDINE; APAMIN; CHARYBDOTOXIN; GLIBENCLAMIDE; MUSCARINIC AGENT; MUSCARINIC M2 RECEPTOR; NORADRENALIN; OXOTREMORINE; PARGYLINE; PHENTOLAMINE; POTASSIUM CHANNEL; POTASSIUM CHANNEL BLOCKING AGENT; TETRYLAMMONIUM; TETRYLAMMONIUM CHLORIDE;

ANIMAL EXPERIMENT; ARTICLE; CONTROLLED STUDY; DOSE RESPONSE; ELECTROSTIMULATION; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; MALE; NEUROTRANSMISSION; NONHUMAN; NORADRENALIN RELEASE; POTASSIUM CURRENT; RAT; STATISTICAL ANALYSIS; STOMACH; SYMPATHETIC NERVE;

EID: 10944250256     PISSN: 13478613     EISSN: None     Source Type: Journal    
DOI: 10.1254/jphs.FPJ04036X     Document Type: Article

References (39)

1. Nicoll RA, Malenka RC, Kauer JA. Functional comparison of neurotransmitter receptor subtypes in mammalian central nervous system. Physiol Rev. 1990;70:513-565.
2. Roeper J, Pongs O. Presynaptic potassium channels. Curr Opin Neurobiol. 1996;6:338-341.
3. Mathie A, Wooltorton JR, Watkins CS. Voltage-activated potassium channels in mammalian neurons and their block by novel pharmacological agents. Gen Pharmacol. 1998;30:13-24.
4. Reimann F, Ashcroft FM. Inwardly rectifying potassium channels. Curr Opin Cell Biol. 1999;11:503-508.
5. Sanguinetti MC, Spector PS. Potassium channelopathies. Neuropharmacology. 1997;36:755-762.
6. Aronson JK. Potassium channels in nervous tissue. Biochem Pharmacol. 1992;43:11-14.
7. Yokotani K, Osumi Y. Cholinergic M: muscarinic receptor-mediated inhibition of endogenous noradrenaline release from the isolated vascularly perfused rat stomach. J Pharmacol Exp Ther. 1993;264:54-60.
8. Yokotani K, Okuma Y, Osumi Y. Release of endogenous noradrenaline from the vascularly perfused rat stomach in vitro: modulation by pre- and postsynaptic adrenoceptors. J Pharmacol Exp Ther. 1992;260:728-733.
9. Nakamura K, Okada S, Yokotani K. Endothelin ET A- and ET B-receptor-mediated inhibition of noradrenaline release from isolated rat stomach. J Pharmacol Sci. 2003;91:34-40.
10. 2α on the release of noradrenaline from the isolated rat stomach. Eur J Pharmacol. 2003;470:73-78.
11. Anton AH, Sayre DF. A study of the factors affecting the aluminum oxide-trihydroxyindole procedure for the analysis of catecholamines. J Pharmacol Exp Ther. 1962;138:360-375.
12. 2 and centrally activates adrenomedullary outflow in rats. Neuroscience. 2000; 96:585-590.
13. Starke K, Gothert M, Kilbinger H. Modulation of neurotransmitter release by presynaptic autoreceptors. Physiol Rev. 1989;69:864-989.
14. + channel blockers in rat vas deferens. Eur J Pharmacol. 1995;287:287-293.
15. Stanfield PR. Tetraethylammonium ions and the potassium permeability of excitable cells. Rev Physiol Biochem Pharmacol. 1983;97:1-67.
16. Adams DJ, Harper AA. Electrophysiological properties of autonomic ganglion neurons. In: McLachlan EM, editor. Autonomic ganglia. London: Harwood Academic Publishers; 1995. p. 153-212.
17. Cook NS, Quast U. Potassium channel pharmacology. In: Cook NS, editor. Potassium channels: structure, classification, function and therapeutic potential. London: Ellis Horwood Ltd; 1990. p. 181-258.
18. Glover WE. The aminopyridines. Gen Pharmacol. 1982;13:259-285.
19. Baker M, Howe JR, Ritchie JM. Two types of 4-aminopyridine-sensitive potassium current in rabbit Schwann cells. J Physiol (Lond). 1993;464:321-342.
20. Rogawski MA. Tetrahydroaminoacridine blocks voltage-dependent ion channels in hippocampal neurons. Eur J Pharmacol. 1987;142:169-172.
21. + channel blockers. Br J Pharmacol. 1998;125:1669-1676.
22. 2+ channels in the relaxation of rabbit facial vein. Naunyn Schmiedebergs Arch Pharmacol. 2003;367:35-42.
23. Ikushima S, Muramatsu I, Fujiwara M. Effects of 4-amino-pyridine on the adrenergic nerve terminals of rabbit arteries. J Pharmacol Exp Ther. 1981;219:792-797.
24. Zygmunt PK, Hogestatt ED, Andersson KE. Effects of potassium channel inhibitors on nitrergic and adrenergic neurotransmission in lamina propria of the female rabbit urethra. Naunyn Schmiedebergs Arch Pharmacol. 1996;354:336-342.
25. 3H]noradrenaline release from rat hippocampus. Eur J Pharmacol. 1991;209:87-93.
26. + channels. Eur Respir J. 1998;11:571-574.
27. Corriu C, Feletou M, Canet E, Vanhoutte PM. Endothelium-derived factors and hyperpolarization of the carotid artery of the guinea-pig. Br J Pharmacol. 1996;119:959-964.
28. + channels. Toxicon. 1998;36:641-650.
29. + channels in cardiac muscle. Nature. 1983;305:47-48.
30. + channels. Ren Physiol Biochem. 1994;17:118-120.
31. +-channel activators and inhibitors in guinea-pig and human isolated right atrium. Cardiovasc Res. 1999;43:125-134.
32. Garcia ML, Hanner M, Knaus HG, Koch R, Schmalhofer W, Slaughter RS, et al. Pharmacology of potassium channels. Adv Pharmacol. 1997;39:425-471.
33. Noma A, Trautwein W. Relaxation of the ACh-induced potassium current in the rabbit sinoatrial node cell. Pflugers Arch. 1978;377:193-200.
34. + channels in isolated pacemaker cells of the mammalian heart. Nature. 1983;303:250-253.
35. Yamada M, Inanobe A, Kurachi Y. G protein regulation of potassium ion channels. Pharmacol Rev. 1998;50:723-760.
36. Pfaffinger PJ, Martin JM, Hunter DD, Nathanson NM, Hille B. GTP-binding proteins couple cardiac muscarinic receptors to a K channel. Nature. 1985;317:536-538.
37. + channels in cell-free membrane of atrial cells. Am J Physiol. 1986;251:H681-H684.
38. ACh) in acetylcholine-induced atrioventricular blocks. Br J Pharmacol. 2000;131:569-577.
39. + channels in rabbit cardiac myocytes. J Pharmacol Exp Ther. 2000;293:196-205.